{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T06:14:05Z","timestamp":1765347245447,"version":"3.46.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,9]]},"DOI":"10.7759\/cureus.98852","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T06:09:20Z","timestamp":1765346960000},"source":"Crossref","is-referenced-by-count":0,"title":["Asymptomatic Cryptococcal Antigenemia: A Multi-clinic Cross-Sectional Study on the Prevalence, Associated Factors and Predictors of Three-Month Outcomes Among Antiretroviral-Na\u00efve and Antiretroviral-Experienced HIV Patients in Dar es Salaam, Tanzania"],"prefix":"10.7759","author":[{"given":"Mandela","family":"Makakala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mukasa","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mabula M","family":"Mabelele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamran","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip B","family":"Adebayo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6573672","article-title":"Pattern, clinical characteristics, and outcome of meningitis among HIV-infected adults admitted in a tertiary hospital in north western Tanzania: a cross-sectional study","volume":"2016","author":"Boaz MM","year":"2016","unstructured":"Boaz MM, Kalluvya S, Downs JA, Mpondo BC, Mshana SE. Pattern, clinical characteristics, and outcome of meningitis among HIV-infected adults admitted in a tertiary hospital in north western Tanzania: a cross-sectional study. J Trop Med. 2016, 2016:6573672. 10.1155\/2016\/6573672","journal-title":"J Trop Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200007070-00013","article-title":"Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients","volume":"14","author":"Hakim JG","year":"2000","unstructured":"Hakim JG, Gangaidzo IT, Heyderman RS, et al.. Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS. 2000, 14:1401-7. 10.1097\/00002030-200007070-00013","journal-title":"AIDS"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.167","article-title":"Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy","volume":"13","author":"Williamson PR","year":"2017","unstructured":"Williamson PR, Jarvis JN, Panackal AA, Fisher MC, Molloy SF, Loyse A, Harrison TS. Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy. Nat Rev Neurol. 2017, 13:13-24. 10.1038\/nrneurol.2016.167","journal-title":"Nat Rev Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005575","article-title":"Cryptococcal meningitis: a neglected NTD?","volume":"11","author":"Molloy SF","year":"2017","unstructured":"Molloy SF, Chiller T, Greene GS, et al.. Cryptococcal meningitis: a neglected NTD?. PLoS Negl Trop Dis. 2017, 11:e0005575. 10.1371\/journal.pntd.0005575","journal-title":"PLoS Negl Trop Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70078-1","article-title":"Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries","volume":"13","author":"Loyse A","year":"2013","unstructured":"Loyse A, Thangaraj H, Easterbrook P, et al.. Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries. Lancet Infect Dis. 2013, 13:629-37. 10.1016\/S1473-3099(13)70078-1","journal-title":"Lancet Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-010-0052-6","article-title":"Management of cryptococcal meningitis in Sub-Saharan Africa","volume":"7","author":"Jackson A","year":"2010","unstructured":"Jackson A, Hosseinipour MC. Management of cryptococcal meningitis in Sub-Saharan Africa. Curr HIV\/AIDS Rep. 2010, 7:134-42. 10.1007\/s11904-010-0052-6","journal-title":"Curr HIV\/AIDS Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000872","article-title":"Six-month outcomes of HIV-infected patients given short-course fluconazole therapy for asymptomatic cryptococcal antigenemia","volume":"29","author":"Kapoor SW","year":"2015","unstructured":"Kapoor SW, Magambo KA, Kalluvya SE, Fitzgerald DW, Peck RN, Downs JA. Six-month outcomes of HIV-infected patients given short-course fluconazole therapy for asymptomatic cryptococcal antigenemia. AIDS. 2015, 29:2473-8. 10.1097\/QAD.0000000000000872","journal-title":"AIDS"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(22)00499-6","article-title":"The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis","volume":"22","author":"Rajasingham R","year":"2022","unstructured":"Rajasingham R, Govender NP, Jordan A, et al.. The global burden of HIV-associated cryptococcal infection in adults in 2020: a modelling analysis. Lancet Infect Dis. 2022, 22:1748-55. 10.1016\/s1473-3099(22)00499-6","journal-title":"Lancet Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32832be0fc","article-title":"High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out","volume":"23","author":"Jarvis JN","year":"2009","unstructured":"Jarvis JN, Boulle A, Loyse A, et al.. High ongoing burden of cryptococcal disease in Africa despite antiretroviral roll out. AIDS. 2009, 23:1182-3. 10.1097\/QAD.0b013e32832be0fc","journal-title":"AIDS"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1086\/518607","article-title":"Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole","volume":"45","author":"Bicanic T","year":"2007","unstructured":"Bicanic T, Meintjes G, Wood R, Hayes M, Rebe K, Bekker LG, Harrison T. Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole. Clin Infect Dis. 2007, 45:76-80. 10.1086\/518607","journal-title":"Clin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00731-4","article-title":"Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM","volume":"24","author":"Chang CC","year":"2024","unstructured":"Chang CC, Harrison TS, Bicanic TA, et al.. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM. Lancet Infect Dis. 2024, 24:e495-512. 10.1016\/S1473-3099(23)00731-4","journal-title":"Lancet Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2007.01874.x","article-title":"Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda","volume":"12","author":"Liechty CA","year":"2007","unstructured":"Liechty CA, Solberg P, Were W, et al.. Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop Med Int Health. 2007, 12:929-35. 10.1111\/j.1365-3156.2007.01874.x","journal-title":"Trop Med Int Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161830","article-title":"Estimated prevalence of Cryptococcus antigenemia (CrAg) among HIV-infected adults with advanced immunosuppression in Namibia justifies routine screening and preemptive treatment","volume":"11","author":"Sawadogo S","year":"2016","unstructured":"Sawadogo S, Makumbi B, Purfield A, et al.. Estimated prevalence of Cryptococcus antigenemia (CrAg) among HIV-infected adults with advanced immunosuppression in Namibia justifies routine screening and preemptive treatment. PLoS One. 2016, 11:e0161830. 10.1371\/journal.pone.0161830","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2012.51","article-title":"Screening for cryptococcal antigenemia in anti-retroviral na\u00efve AIDS patients in Benin city, Nigeria","volume":"27","author":"Osazuwa F","year":"2012","unstructured":"Osazuwa F, Dirisu JO, Okuonghae PE, Ugbebor O. Screening for cryptococcal antigenemia in anti-retroviral na\u00efve AIDS patients in Benin city, Nigeria. Oman Med J. 2012, 27:228-31. 10.5001\/omj.2012.51","journal-title":"Oman Med J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.17.1.18821","article-title":"Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia","volume":"17","author":"Ganiem AR","year":"2014","unstructured":"Ganiem AR, Indrati AR, Wisaksana R, Meijerink H, van der Ven A, Alisjahbana B, van Crevel R. Asymptomatic cryptococcal antigenemia is associated with mortality among HIV-positive patients in Indonesia. J Int AIDS Soc. 2014, 17:18821. 10.7448\/IAS.17.1.18821","journal-title":"J Int AIDS Soc"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2652-15-15","article-title":"Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study","volume":"15","author":"Oyella J","year":"2012","unstructured":"Oyella J, Meya D, Bajunirwe F, Kamya MR. Prevalence and factors associated with cryptococcal antigenemia among severely immunosuppressed HIV-infected adults in Uganda: a cross-sectional study. J Int AIDS Soc. 2012, 15:15. 10.1186\/1758-2652-15-15","journal-title":"J Int AIDS Soc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.09.014","article-title":"The prevalence of cryptococcal antigenemia in newly diagnosed HIV patients in a Southwest London cohort","volume":"66","author":"Patel S","year":"2013","unstructured":"Patel S, Shin GY, Wijewardana I, et al.. The prevalence of cryptococcal antigenemia in newly diagnosed HIV patients in a Southwest London cohort. J Infect. 2013, 66:75-9. 10.1016\/j.jinf.2012.09.014","journal-title":"J Infect"},{"key":"ref18","article-title":"Prevalence of cryptococcal antigen positivity among HIV infected patient with CD4 cell count less than 100 of Imam Khomeini Hospital, Tehran, Iran","volume":"9","author":"Hajiabdolbaghi M","year":"2017","unstructured":"Hajiabdolbaghi M, Kalantari S, Jamshidi-Makiani M, Shojaei E, Abbasian L, Rasoulinezhad M, Tayeri K. Prevalence of cryptococcal antigen positivity among HIV infected patient with CD4 cell count less than 100 of Imam Khomeini Hospital, Tehran, Iran. Iran J Microbiol. 2017, 9:119-21.","journal-title":"Iran J Microbiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058377","article-title":"High prevalence of cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia","volume":"8","author":"Alemu AS","year":"2013","unstructured":"Alemu AS, Kempker RR, Tenna A, et al.. High prevalence of cryptococcal antigenemia among HIV-infected patients receiving antiretroviral therapy in Ethiopia. PLoS One. 2013, 8:e58377. 10.1371\/journal.pone.0058377","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/mbo3.746","article-title":"Cryptococcal antigenemia and associated risk factors among ART-na\u00efve and ART-experienced HIV-infected peoples at selected health institutions of Mekelle, Northern Ethiopia","volume":"8","author":"Hailu K","year":"2019","unstructured":"Hailu K, Niguse S, Hagos K, Abdulkader M. Cryptococcal antigenemia and associated risk factors among ART-na\u00efve and ART-experienced HIV-infected peoples at selected health institutions of Mekelle, Northern Ethiopia. Microbiologyopen. 2019, 8:e00746. 10.1002\/mbo3.746","journal-title":"Microbiologyopen"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075585","article-title":"Comparison of cryptococcal antigenemia between antiretroviral na\u00efve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia","volume":"8","author":"Beyene T","year":"2013","unstructured":"Beyene T, Woldeamanuel Y, Asrat D, Ayana G, Boulware DR. Comparison of cryptococcal antigenemia between antiretroviral na\u00efve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia. PLoS One. 2013, 8:e75585. 10.1371\/journal.pone.0075585","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2652-14-48","article-title":"Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study","volume":"14","author":"Wajanga BM","year":"2011","unstructured":"Wajanga BM, Kalluvya S, Downs JA, Johnson WD, Fitzgerald DW, Peck RN. Universal screening of Tanzanian HIV-infected adult inpatients with the serum cryptococcal antigen to improve diagnosis and reduce mortality: an operational study. J Int AIDS Soc. 2011, 14:48. 10.1186\/1758-2652-14-48","journal-title":"J Int AIDS Soc"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60164-7","article-title":"Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial","volume":"385","author":"Mfinanga S","year":"2015","unstructured":"Mfinanga S, Chanda D, Kivuyo SL, et al.. Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial. Lancet. 2015, 385:2173-82. 10.1016\/S0140-6736(15)60164-7","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1086\/597262","article-title":"Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa","volume":"48","author":"Jarvis JN","year":"2009","unstructured":"Jarvis JN, Lawn SD, Vogt M, Bangani N, Wood R, Harrison TS. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. Clin Infect Dis. 2009, 48:856-62. 10.1086\/597262","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw055","article-title":"Cryptococcal antigenemia in Nigerian patients with advanced human immunodeficiency virus: influence of antiretroviral therapy adherence","volume":"3","author":"Oladele RO","year":"2016","unstructured":"Oladele RO, Akanmu AS, Nwosu AO, Ogunsola FT, Richardson MD, Denning DW. Cryptococcal antigenemia in Nigerian patients with advanced human immunodeficiency virus: influence of antiretroviral therapy adherence. Open Forum Infect Dis. 2016, 3:ofw055. 10.1093\/ofid\/ofw055","journal-title":"Open Forum Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0145578","article-title":"Epidemiology of drug use and HIV-related risk behaviors among people who inject drugs in Mwanza, Tanzania","volume":"10","author":"Tan AX","year":"2015","unstructured":"Tan AX, Kapiga S, Khoshnood K, Bruce RD. Epidemiology of drug use and HIV-related risk behaviors among people who inject drugs in Mwanza, Tanzania. PLoS One. 2015, 10:e0145578. 10.1371\/journal.pone.0145578","journal-title":"PLoS One"},{"key":"ref27","unstructured":"National Bureau of Statistics. Tanzania in figure 2014. (2015). https.\/\/www.nbs.go.tz\/nbs\/takwimu\/references\/Tanzania_in_Figures_2014.pdf."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/1545109712459077","article-title":"Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation","volume":"11","author":"Jarvis JN","year":"2012","unstructured":"Jarvis JN, Govender N, Chiller T, et al.. Cryptococcal antigen screening and preemptive therapy in patients initiating antiretroviral therapy in resource-limited settings: a proposed algorithm for clinical implementation. J Int Assoc Physicians AIDS Care (Chic). 2012, 11:374-9. 10.1177\/1545109712459077","journal-title":"J Int Assoc Physicians AIDS Care (Chic)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/jan.12462","article-title":"Nutritional status and its health-related factors among older adults in rural and urban areas","volume":"71","author":"Chen SH","year":"2015","unstructured":"Chen SH, Cheng HY, Chuang YH, Shao JH. Nutritional status and its health-related factors among older adults in rural and urban areas. J Adv Nurs. 2015, 71:42-53. 10.1111\/jan.12462","journal-title":"J Adv Nurs"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count \u2264100 cells\/\u03bcL who start HIV therapy in resource-limited settings","volume":"51","author":"Meya DB","year":"2010","unstructured":"Meya DB, Manabe YC, Castelnuovo B, et al.. Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count \u2264100 cells\/\u03bcL who start HIV therapy in resource-limited settings. Clin Infect Dis. 2010, 51:448-55. 10.1086\/655143","journal-title":"Clin Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofv046","article-title":"Cryptococcal antigenemia in immunocompromised human immunodeficiency virus patients in rural Tanzania: a preventable cause of early mortality","volume":"2","author":"Letang E","year":"2015","unstructured":"Letang E, M\u00fcller MC, Ntamatungiro AJ, et al.. Cryptococcal antigenemia in immunocompromised human immunodeficiency virus patients in rural Tanzania: a preventable cause of early mortality. Open Forum Infect Dis. 2015, 2:ofv046. 10.1093\/ofid\/ofv046","journal-title":"Open Forum Infect Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189460","article-title":"Predictors of non-adherence to antiretroviral therapy among HIV infected patients in northern Tanzania","volume":"12","author":"Semvua SK","year":"2017","unstructured":"Semvua SK, Orrell C, Mmbaga BT, Semvua HH, Bartlett JA, Boulle AA. Predictors of non-adherence to antiretroviral therapy among HIV infected patients in northern Tanzania. PLoS One. 2017, 12:e0189460. 10.1371\/journal.pone.0189460","journal-title":"PLoS One"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/426527-asymptomatic-cryptococcal-antigenemia-a-multi-clinic-cross-sectional-study-on-the-prevalence-associated-factors-and-predictors-of-three-month-outcomes-among-antiretroviral-nave-and-antiretroviral-experienced-hiv-patients-in-dar-es-salaam-tanzania","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T06:09:22Z","timestamp":1765346962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/426527-asymptomatic-cryptococcal-antigenemia-a-multi-clinic-cross-sectional-study-on-the-prevalence-associated-factors-and-predictors-of-three-month-outcomes-among-antiretroviral-nave-and-antiretroviral-experienced-hiv-patients-in-dar-es-salaam-tanzania"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.98852","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,9]]}}}